 |
(3S)-1-azabicylo[2.2.2]oct-3yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate |
|---|---|
| Trade Name | |
| Orphan Indication | Fabry disease |
| USA Market Approval | USA |
| USA Designation Date | 2014-08-26 00:00:00 |
| Sponsor | Genzyme Corporation;500 Kendall Street;Cambridge, Massachusetts, 01242 |
Related Access Program